Zimmer Biomet has reported third-quarter net sales of $1.824 billion, an increase of 4% over the prior year, according to the company's third-quarter financial report, released Oct. 30.
Here are five additional things to know about Zimmer Biomet's third-quarter financial results:
1. Zimmer Biomet saw net earnings of $249.1 million, or $353.2 million on an adjusted basis.
2. During the quarter, the company announced the broad commercial launch of the Z1 Femoral Hip System for total hip arthroplasty.
3. Zimmer Biomet acquired OrthoGrid Systems Inc., a privately held medical technology company focused on artificial intelligence-driven surgical guidance systems for total hip replacement.
4. Zimmer Biomet recorded a 53.1% bottom-line gain on a sales uptick of 4%.
5. The company now expects full-year revenue growth between 3.5% and 4%, versus its previous projected range of 4% to 5%.